M Hershkop - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M Hershkop

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Postgraduate Medicine|November 21, 1998

When to use bone scintigraphy. It can reveal things other studies cannotA Hendler, M Hershkop

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997

Outcome of hepatobiliary scanning in neonatal hepatitis syndromeS M Gilmour, M Hershkop, R Reifen, et al.

Nuclear Medicine Communications|December 5, 2002

A phase I study of 99mTc-hR3 (DiaCIM), a humanized immunoconjugate directed towards the epidermal growth factor receptorK A Vallis, R M Reilly, P Chen, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Postgraduate Medicine|November 21, 1998

When to use bone scintigraphy. It can reveal things other studies cannotA Hendler, M Hershkop

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 1997

Outcome of hepatobiliary scanning in neonatal hepatitis syndromeS M Gilmour, M Hershkop, R Reifen, et al.

Nuclear Medicine Communications|December 5, 2002

A phase I study of 99mTc-hR3 (DiaCIM), a humanized immunoconjugate directed towards the epidermal growth factor receptorK A Vallis, R M Reilly, P Chen, et al.

Pageof 1